Xiaobo Zhong - Search Results

Year	Number of Results
2003	1
2005	1
2006	2
2007	3
2008	3
2009	6
2010	5
2011	3
2012	9
2013	11
2014	12
2015	12
2016	13
2017	16
2018	11
2019	12
2020	13
2021	17
2022	20
2023	11
2024	3

1

The growth of siRNA-based therapeutics: Updated clinical studies.

Zhang MM, Bahal R, Rasmussen TP, Manautou JE, Zhong XB. Zhang MM, et al. Biochem Pharmacol. 2021 Jul;189:114432. doi: 10.1016/j.bcp.2021.114432. Epub 2021 Jan 26. Biochem Pharmacol. 2021. PMID: 33513339 Free PMC article. Review.

2

Adverse Drug Reactions and Toxicity of the Food and Drug Administration-Approved Antisense Oligonucleotide Drugs.

Alhamadani F, Zhang K, Parikh R, Wu H, Rasmussen TP, Bahal R, Zhong XB, Manautou JE. Alhamadani F, et al. Drug Metab Dispos. 2022 Jun;50(6):879-887. doi: 10.1124/dmd.121.000418. Epub 2022 Feb 27. Drug Metab Dispos. 2022. PMID: 35221289 Free PMC article. Review.

3

Absorption, Distribution, Metabolism, and Excretion of US Food and Drug Administration-Approved Antisense Oligonucleotide Drugs.

Migliorati JM, Liu S, Liu A, Gogate A, Nair S, Bahal R, Rasmussen TP, Manautou JE, Zhong XB. Migliorati JM, et al. Drug Metab Dispos. 2022 Jun;50(6):888-897. doi: 10.1124/dmd.121.000417. Epub 2022 Feb 27. Drug Metab Dispos. 2022. PMID: 35221287 Free PMC article. Review.

4

Special Section on Xenobiotic Receptors-Editorial.

Zhong XB, Lai Y. Zhong XB, et al. Drug Metab Dispos. 2023 Feb;51(2):205-206. doi: 10.1124/dmd.122.001207. Drug Metab Dispos. 2023. PMID: 36702490 No abstract available.

5

Emerging Therapeutic Modalities against COVID-19.

Malik S, Gupta A, Zhong X, Rasmussen TP, Manautou JE, Bahal R. Malik S, et al. Among authors: zhong x. Pharmaceuticals (Basel). 2020 Aug 8;13(8):188. doi: 10.3390/ph13080188. Pharmaceuticals (Basel). 2020. PMID: 32784499 Free PMC article. Review.

6

A holistic analysis of the intrinsic and delivery-mediated toxicity of siRNA therapeutics.

Ranjbar S, Zhong XB, Manautou J, Lu X. Ranjbar S, et al. Adv Drug Deliv Rev. 2023 Oct;201:115052. doi: 10.1016/j.addr.2023.115052. Epub 2023 Aug 9. Adv Drug Deliv Rev. 2023. PMID: 37567502 Review.

7

Isoniazid metabolism and hepatotoxicity.

Wang P, Pradhan K, Zhong XB, Ma X. Wang P, et al. Acta Pharm Sin B. 2016 Sep;6(5):384-392. doi: 10.1016/j.apsb.2016.07.014. Epub 2016 Aug 3. Acta Pharm Sin B. 2016. PMID: 27709007 Free PMC article. Review.

8

Targeting the Liver with Nucleic Acid Therapeutics for the Treatment of Systemic Diseases of Liver Origin.

Gogate A, Belcourt J, Shah M, Wang AZ, Frankel A, Kolmel H, Chalon M, Stephen P, Kolli A, Tawfik SM, Jin J, Bahal R, Rasmussen TP, Manautou JE, Zhong XB. Gogate A, et al. Pharmacol Rev. 2023 Dec 15;76(1):49-89. doi: 10.1124/pharmrev.123.000815. Pharmacol Rev. 2023. PMID: 37696583 Review.

9

Special Section on Drug Metabolism and Precision Medicine-Editorial.

Zhong XB, Lai Y. Zhong XB, et al. Drug Metab Dispos. 2023 Mar;51(3):348-349. doi: 10.1124/dmd.122.001243. Drug Metab Dispos. 2023. PMID: 36849441 No abstract available.

10

Epigenetic Mechanisms Contribute to Intraindividual Variations of Drug Metabolism Mediated by Cytochrome P450 Enzymes.

Jin J, Zhong XB. Jin J, et al. Drug Metab Dispos. 2023 Jun;51(6):672-684. doi: 10.1124/dmd.122.001007. Epub 2023 Mar 27. Drug Metab Dispos. 2023. PMID: 36973001 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

157 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

157 results

Results by year